New Evidence Shows COVID-19 Was in US Weeks Before Thought
New Evidence Shows COVID-19 Was in US Weeks Before Thought
Some of the blood specimens collected in the United States for the NIH’s All of Us research program starting on January 2, 2020, have antibodies against SARS-CoV-2.
New Evidence Shows COVID-19 Was in US Weeks Before Thought
New Evidence Shows COVID-19 Was in US Weeks Before Thought

Some of the blood specimens collected in the United States for the NIH’s All of Us research program starting on January 2, 2020, have antibodies against SARS-CoV-2.

Some of the blood specimens collected in the United States for the NIH’s All of Us research program starting on January 2, 2020, have antibodies against SARS-CoV-2.

antibody
Scientific Breakthroughs with Cryogenic Electron Microscopy
Scientific Breakthroughs with Cryogenic Electron Microscopy
The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific | Jun 10, 2021
Structures made via cryo-EM give researchers insights into SARS-CoV-2, HIV, neurological disorders, cancer, and more.
Advancing Cancer Biomarker Detection with Single Cell Proteomics
Advancing Cancer Biomarker Detection with Single Cell Proteomics
The Scientist Creative Services Team in Collaboration with IsoPlexis | May 31, 2021
An improved ELISA-based proteomics chip detects cytokines in single cell applications.
Technique Talk: ELISA Tips and Tricks
Technique Talk: ELISA Tips and Tricks
The Scientist Creative Services Team | May 14, 2021
Learn to optimize ELISA experiments in this workshop.
Identifying Antibodies that Target Membrane Proteins in Their Native Conformations
Identifying Antibodies that Target Membrane Proteins in Their Native Conformations
The Scientist Creative Services Team in collaboration with OXGENE | May 10, 2021
A new mammalian display platform enhances antibody discovery for challenging protein targets.
Optimizing Fluorescence-Activated Cell Sorting
Optimizing Fluorescence-Activated Cell Sorting
The Scientist Creative Services Team in Collaboration with BD Biosciences | Apr 12, 2021
Karen Ersland, David Haviland, and Dagna Sheerar discuss how to obtain the best cell samples possible using fluorescence-activated cell sorting.
Making IHC as Simple as ABC
Making IHC as Simple as ABC
The Scientist Creative Services Team | Apr 1, 2021
A guide for optimizing immunohistochemistry protocols
A Guide to Immunofluorescence Staining
A Guide to Immunofluorescence Staining
The Scientist Creative Services Team | Apr 1, 2021
How to optimize immunofluorescence staining for best results.
LabTalk Podcast - Predicting the Immune Response with Single-Cell Analysis: Autoimmunity, Vaccination, and COVID-19
LabTalk Podcast - Predicting the Immune Response with Single-Cell Analysis: Autoimmunity, Vaccination, and COVID-19
The Scientist Staff | Mar 31, 2021
Researchers identify signatures that predict how a person will respond to an immune system stimulus.
Precise Spatial Phenotyping with ChipCytometry
Precise Spatial Phenotyping with ChipCytometry
The Scientist Creative Services Team | Mar 18, 2021
Combining spatial context with multiplexing depth for cell characterization
What Pseudoviruses Bring to the Study of SARS-CoV-2
What Pseudoviruses Bring to the Study of SARS-CoV-2
Amanda Heidt | Feb 16, 2021
Engineered viruses that don’t replicate provide a tractable model for scientists to safely study SARS-CoV-2, including research into vaccine efficacy and emerging variants.
SARS-CoV-2 with Genomic Deletions Escapes an Antibody
SARS-CoV-2 with Genomic Deletions Escapes an Antibody
Abby Olena | Feb 16, 2021
Researchers identify deletions in the N-terminal domain of the spike protein that allow the coronavirus to avoid antibody neutralization and that may contribute to the emergence of new variants.
Vaccines Versus the Mutants
Vaccines Versus the Mutants
Anthony King | Feb 8, 2021
Facing new variants of SARS-CoV-2, some vaccines may offer more robust protection or be more easily redesigned to target them.
COVID-19 May Have Arrived in US in December: Study
COVID-19 May Have Arrived in US in December: Study
Max Kozlov | Dec 2, 2020
SARS-CoV-2 antibodies detected in blood donor samples indicate infections could have occurred in the US more than a month before the first confirmed case, but some experts remain skeptical.
Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
Anthony King | Nov 11, 2020
Outcomes in COVID-19 patients may be better in those recently infected with endemic coronaviruses. 
Vast Majority in US Remain Susceptible to COVID-19: Study
Vast Majority in US Remain Susceptible to COVID-19: Study
Max Kozlov | Sep 28, 2020
Fewer than 1 in 10 dialysis patients sampled had antibodies against the novel coronavirus as of July, indicating that the greater population is far from levels required to achieve herd immunity.
Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic
Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic
Anthony King | Sep 8, 2020
Adenovirus vectors deliver the genetic instructions for SARS-CoV-2 antigens directly into patients’ cells, provoking a robust immune response. But will pre-existing immunity from common colds take them down?
Zika Infection Increases Risk of Severe Dengue Fever
Zika Infection Increases Risk of Severe Dengue Fever
Ruth Williams | Aug 27, 2020
A study of Nicaraguan children links prior Zika virus infection with aggravated dengue fever symptoms.